Skip to main content
Premium Trial:

Request an Annual Quote

Pressure BioSciences Nets $161K SBIR Grant

NEW YORK (GenomeWeb News) – Pressure BioSciences has received a $160,978 grant from the National Institutes of Health to develop a system for processing and preserving tissue samples in order to improve the tissue fixation process, the company announced today.

The Phase I Small Business Innovation Research grant from the National Institute of General Medical Sciences will be used to develop a "high pressure system for the automated processing and preservation of tissue samples to facilitate, standardize, and improve the tissue fixation process independent of sample size and tissue type," Pressure Bio said.

If successful in its Phase I work, the South Easton, Mass.-based firm expects to apply for a SBIR Phase II grant, which could bring in $1 million over a two-year period, Pressure Bio added.

The grant follows a May 2010 Cooperative Research and Development Agreement with the Armed Forces Institute of Pathology, the American Registry of Pathology, and the US Department of Veterans Affairs to develop pressure-based sample preparation methods for formalin-fixed paraffin embedded tissue.

The Scan

Not as High as Hoped

The Associated Press says initial results from a trial of CureVac's SARS-CoV-2 vaccine suggests low effectiveness in preventing COVID-19.

Finding Freshwater DNA

A new research project plans to use eDNA sampling to analyze freshwater rivers across the world, the Guardian reports.

Rise in Payments

Kaiser Health News investigates the rise of payments made by medical device companies to surgeons that could be in violation of anti-kickback laws.

Nature Papers Present Ginkgo Biloba Genome Assembly, Collection of Polygenic Indexes, More

In Nature this week: a nearly complete Ginkgo biloba genome assembly, polygenic indexes for dozens of phenotypes, and more.